Dr. Stephen Klein

speaker

550 appearances 1 recordings 1 series first heard Jun 2026 last heard 25 Jun

Dr. Stephen Klein’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.

newest first · ▶ plays the moment

So danger is relative.

I think they can be more dangerous because they're appearing in more and more parts of the population.

For example, I live in downtown Philadelphia.

A Kratom drink shop just opened up down the street from me.

So they sell kava and Kratom mixed into what is billed as a health drink.

So people are buying these things, potentially being unsuspecting that they're taking opioids.

I think people would feel very differently if they were drinking, you know, tumor-confused heroin.

But these are marketed in a way that they're fully natural and all of that.

All of the opioids, everything in the class, is a derivative or a synthetic derivative of opium.

Opium comes from poppy seeds.

That's really the base of this class.

And all of the derivatives just affect people differently as far as potency and half-life and all of those things.

So it's a really great question that requires a little bit of nuance.

I think for abstinence, we have to be really careful about meeting patients where they are.

For opioid use disorder, it's pretty hard to imagine a world where people are casually doing something like heroin or fentanyl.

Those drugs have really profound effects on quality of life and people's ability to

interact with society, to maintain jobs, to do things that they want to be doing.

So abstinence from their drug of choice, whether that be heroin or fentanyl, is I think certainly the goal of most interventions.

I would say as a field in addiction medicine, really our first goal is to decrease morbidity and mortality.

So how do we really stop people from overdosing and

Showing 61–80 of 550 · page 4 of 28